Activation of transforming growth factor-β1 in diabetic kidney disease

Metabolism: Clinical and Experimental

Volumn 49, Issue 3, 2000, Pages 353-359

  Hellmich, Bernhard ^a,b   Schellner, Matthias ^a,b   Schatz, Helmut ^a,b   Pfeiffer, Andreas ^a,b  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b Medionische Klinik   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CREATININE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETIC NEPHROPATHY; DISEASE ASSOCIATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEINURIA;

EID: 0034064205     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(00)90264-6     Document Type: Article

References (55)

1. UK Prospective Diabetes Study (UKPDS) Group: Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). Lancet 352:854-865, 1998
2. Mauer SM: Structural-functional correlations of diabetic nephropathy. Kidney Int 45:612-622, 1993
3. Kimmelstiel P, Wilson C: Intercapillary lesions in glomeruli of kidney. Am J Pathol 12:83-97, 1936
4. Lane PH, Steffes MW, Mauer SM: Renal histologic changes in diabetes mellitus. Semin Nephrol 10:254-259, 1990
5. 1, in patients with type II diabetes. Diabetes 46:854-859, 1997
6. 1 enhances glomerular collagen synthesis in diabetic rats. Diabetes 42:1673-1677, 1993
7. Ziyadeh FN, Sharma K, Ericksen M, et al: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by activation of transforming growth factor-β. J Clin Invest 93:536-542, 1994
8. 1 m-RNA is associated with upregulation of glomerular tension and laminin gene expression in nonobese diabetic mice. J Am Soc Nephrol 5:1610-1617, 1995
9. 1 gene expression in diabetic BB rat and NOD mice. Am J Physiol 267:F1094-F1101, 1994
10. Yamamoto T, Nakamura T, Noble NA, et al: Expression of transforming growth factor β is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 90:1814-1818, 1990
11. 1. Kidney Int 42:647-656, 1992
12. Rocco M, Chen Y, Ericksen M, et al: Elevated glucose stimulates TGF-β gene expression and bioactivity in proximal tubule. Kidney Int 41:107-114, 1992
13. Sharma K, Ziyadeh FN: Hyperglycemia and diabetic kidney disease: The case for transforming growth factor-β as a key mediator. Diabetes 44:1139-1146, 1995
14. 1 during diabetic renal hypertrophy. Kidney Int 46:430-442, 1994
15. Nakamura T, Fukui M, Ebihara I, et al: m-RNA expression of growth factors in glomeruli from diabetic rats. Diabetes 42:450-456, 1993
16. 1 and type IV collagen in early streptozotocin-induced diabetes. Diabetes 46:473-480, 1997
17. 1 in patients with diabetes mellitus. Kidney Int 49:1120-1126, 1996
18. Bertoluci MC, Schmid H, Lachat JJ, et al: Transforming growth factor-beta in the development of rat diabetic nephropathy. Nephron 74:189-196, 1996
19. Sporn MB, Roberts AB, Wakefield LM, et al: Transforming growth factor-beta: Biological function and chemical structure. Science 233:532-534, 1986
20. Sporn MB, Roberts AB, Wakefield LM, et al: Some recent advances in chemistry and biology of transforming growth factor-beta. J Cell Biol 105:1039-1045, 1987
21. Border WA, Noble NA: Targeting TGF-β for treatment of disease. Nat Med 1:1000-1001, 1995
22. 1. Kidney Int 44:948-959, 1993
23. Ziyadeh FN: The extracellular matrix in diabetic nephropathy. Am J Kidney Dis 22:736-744, 1993
24. 1. Kidney Int 41:1213-1221, 1992
25. 1 in experimental glomerulonephritis. Ciba Found Symp 157:425-432, 1990
26. Creely JJ, DiMari SJ, Howe AM, et al: Effects of transforming growth factor-ß on collagen synthesis by normal rat kidney epithelial cells. Am J Pathol 140:45-55, 1992
27. Yamamoto T, Noble NA, Cohen AH, et al: Expression of transforming growth factor-β isoforms in human glomerular diseases. Kidney Int 49:461-469, 1996
28. Graininger DJ, Kemp PR, Metcalfe JC, et al: The serum concentration of active transforming growth factor-β is severely depressed in advanced atherosclerosis. Nat Med 1:74-79, 1995
29. Boswell JM, Yui MA, Burt DW, et al: Increased tumor necrosis factor and IL-1 gene expression in the kidneys of mice with lupus nephritis. J Immunol 141:3050-3054, 1988
30. Pennica D, Nedwin GE, Hayflick JS, et al: Human tumor necrosis factor: Precursor structure, expression and homology to lymphotoxin. Nature 312:724-729, 1984
31. Vilcek J, Lee TH: Tumor necrosis factor. New insights into the molecular mechanisms of its multiple actions. J Biol Chem 266:7313-7316, 1991
32. Hotamisligil GS, Shargill NS, Spiegelmann BM: Adipose expression of tumor necrosis factor-alpha: A direct role in obesity-linked insulin resistance. Science 259:87-91, 1993
33. Hasegawa G, Nakano K, Sawada M, et al: Possible role of tumor necrosis factor and interleukin-1 in the development of diabetic nephropathy. Kidney Int 40:1007-1012, 1991
34. Pfeiffer A, Janott J, Möhlig M, et al: Circulating tumor necrosis factor α is elevated in male but not female patients with type II diabetes mellitus. Horm Metab Res 29:111-114, 1997
35. Katsuki A, Sumida Y, Murashima S, et al: Serum levels of tumor necrosis factor-alpha are increased in obese patients with noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 83:859-862, 1988
36. 1 in NIDDM. Diabetes Care 19:1113-1117, 1996
37. Graininger DJ, Mosedale DE, Metcalfe JC, et al: Active and acid-activatable TGF-β in human sera, platelets and plasma. Clin Chim Acta 235:11-31, 1995
38. Kagami S, Border WA, Miller DE, et al: Angiotensin II stimulates extracellular matrix protein synthesis through induction of transforming growth factor-beta expression in rat glomerular mesangial cells. J Clin Invest 93:2431-2437, 1994
39. Nakamura T, Obata J, Kimura H, et al: Blocking angiotensin II ameliorates proteinuria and glomerular lesions in progressive mesangio-proliferative glomerulonephritis. Kidney Int 55:877-889, 1999
40. Van Det NF, Verhagen NA, Tamsma JT, et al: Regulation of glomerular epithelial cell production of fibronection and transforming growth factor-beta by high glucose, not by angiotensin II. Diabetes 46:834-840, 1997
41. Sato Y, Tusboi R, Lyons R, et al: Characterization of the activation of latent TGF-β by co-cultures of endothelial cells and pericytes or smooth muscle cells: A self regulating system. J Cell Biol 111:757-763, 1990
42. Laiho M, Saksekal O, Andreasen PA, et al: Enhanced production and extracellular deposition of the endothelial type plasminogen activator inhibitor in cultured human lung fibroblasts by transforming growth factor-β. J Cell Biol 103:2403-2410, 1986
43. Gruden G, Cavallo-Perin P, Bazzan M, et al: PAI-1 and factor VII activity are higher in IDDM patients with microalbuminuria. Diabetes 43:426-429, 1994
44. Kramer MD, Schaefer B, Reinartz J: Plasminogen activation by human keratinocytes: Molecular pathways and cell-biological consequences. Biol Chem Hoppe Seyler 376:131-141, 1995
45. Ziyadeh FN, Sharma K, Ericksen M, et al: Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-β. J Clin Invest 93:536-542, 1994
46. Anscher MS, Peters WP, Reisenbichler H, et al: Transforming growth factor beta as a predictor of liver and lung fibrosis after autologous bone marrow transplantation for advanced breast cancer. N Engl J Med 328:1592-1598, 1993
47. Huffman BB, Sharma K, Ziyadeh FN: Potential role of TGF-β in diabetic nephropathy. Miner Electrolyte Metab 24:190-196, 1998
48. 1 enhances glomerular collagen synthesis in diabetic rats. Diabetes 42:1673-1677, 1993
49. 1 develop progressive renal disease. Lab Invest 74:991-1003, 1996
50. Sharma K, Jin Y, Guo J, et al: Neutralization of TGF-β by anti-TGF-β antibody attenuates kidney hypertrophy and enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45:522-530, 1996
51. Yang CW, Vlassara H, Peten EP, et al: Advanced glycation end products up-regulate gene expression found in diabetic glomerular disease. Proc Natl Acad Sci USA 91:9436-9440, 1994
52. Wolf G, Mueller E, Stahl RAK, et al: Angiotensin II induced hypertrophy of cultured murine proximal tubular cells is mediated by endogenous TGF-β. J Clin Invest 92:1366-1373, 1993
53. Hotamisligil GS, Spiegelmann BM: Tumor necrosis factor α: A key component of the obesity-diabetes link. Diabetes 43:1271-1278, 1994
54. Engelberts I, Stephens S, Francot GJ, et al: Evidence for different effects of soluble TNF-receptors on various TNF measurements in human biological fluids. Lancet 338:515-516, 1991
55. Tanaka S, Seino H, Satoh J, et al: Increased in vivo production of tumor necrosis factor after development of diabetes in non-treated, long-term diabetic BB rats. Clin Immunol Immunopathol 62:258-263, 1992